BIT Capital’s Tenaya Therapeutics TNYA Stock Holding History

BIT Capital’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200,668	Closed	-$622K	–	133
2024 Q2	$622K	Hold	200,668	–	–	0.05%	93
2024 Q1	$1.05M	Buy	+200,668	New	+$960K	0.08%	90

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BIT Capital's TNYA Position: Q3 2024 in Review

BIT Capital sold out of Tenaya Therapeutics (TNYA) in Q3 2024, closing a stake of 200,668 shares — an estimated $622K sold.

BIT Capital first reported a position in TNYA in Q1 2024 and held it in 2 quarters. The position peaked at $1.05M in Q1 2024. 95 funds tracked by Wall St. Rank hold TNYA as of Q3 2024.

BIT Capital reported no remaining Tenaya Therapeutics position as of Q3 2024 after selling out during the quarter.
BIT Capital sold 200,668 Tenaya Therapeutics shares in Q3 2024, an estimated $622K.
BIT Capital first reported a position in Tenaya Therapeutics in Q1 2024 and held it in 2 quarters.
BIT Capital's Tenaya Therapeutics position peaked at $1.05M in Q1 2024.
95 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2024.

Based on BIT Capital's 13F filing for Q3 2024, filed 12 Feb 2025.